Page last updated: 2024-08-22

buthionine sulfoximine and Spinal Cord Injuries

buthionine sulfoximine has been researched along with Spinal Cord Injuries in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Etlinger, JD; Feng, Y; Liu, X; Peng, H; Song, H; Zeman, RJ1
Bramanti, P; Cuzzocrea, S; Di Bella, P; Di Paola, R; Esposito, E; Genovese, T; Mazzon, E; MuiĆ , C1

Other Studies

2 other study(ies) available for buthionine sulfoximine and Spinal Cord Injuries

ArticleYear
Beta2-adrenoreceptor agonist-enhanced recovery of locomotor function after spinal cord injury is glutathione dependent.
    Journal of neurotrauma, 2006, Volume: 23, Issue:2

    Topics: Adrenergic beta-Agonists; Animals; Buthionine Sulfoximine; Clenbuterol; Female; Glutamate-Cysteine Ligase; Glutathione Reductase; Motor Activity; Protein Carbonylation; Rats; Rats, Wistar; Recovery of Function; Spinal Cord Injuries

2006
Role of endogenous glutathione in the secondary damage in experimental spinal cord injury in mice.
    Neuroscience letters, 2007, Aug-09, Volume: 423, Issue:1

    Topics: Animals; Antimetabolites; Apoptosis; bcl-2-Associated X Protein; Buthionine Sulfoximine; DNA; Glutathione; Immunohistochemistry; In Situ Nick-End Labeling; Kinetics; Lipid Peroxidation; Male; Malondialdehyde; Mice; Neutrophil Infiltration; Peroxidase; Poly Adenosine Diphosphate Ribose; RNA; Spinal Cord Compression; Spinal Cord Injuries; Tyrosine

2007